Showing results (791-800 of 1,038) with videos related to
Sort By:
Pageof 104
Journal of the National Cancer Institute|September 20, 1995
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cellsG K Schwartz, A Haimovitz-Friedman, S K Dhupar, et al.Gene Therapy|August 30, 2001
Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophiesJ T Vilquin, P F Kennel, M Paturneau-Jouas, et al.The Journal of Clinical Investigation|October 19, 1999
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwayR M Lawn, D P Wade, M R Garvin, et al.Oral Oncology|January 29, 2021
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101Michael J Jelinek, Nathan R Foster, Alex J Zoroufy, et al.Clinical Chemistry|March 1, 1984
Chemical and clinical evaluation of the random access analyzer "RA-1000"M K Schwartz, B E Statland, J Coughlin, et al.European Heart Journal|March 21, 1998
Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndromeN Neyroud, P Maison-Blanche, I Denjoy, et al.Journal of Medical Genetics|October 4, 2002
Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experienceP Charron, D Héron, M Gargiulo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2022
Molecular Subtypes of Head and Neck Cancer in Patients of African AncestryNadia Mezghani, Alexandria Yao, Daria Vasilyeva, et al.Investigational New Drugs|May 23, 2012
A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignanciesJohn F Gerecitano, Joe J Stephenson, Nancy L Lewis, et al.Pageof 104